Literature DB >> 9696496

Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome.

M K Whyte1, J M Hughes, A M Peters, W Ussov, S Patel, A K Burroughs.   

Abstract

BACKGROUND/AIMS: Severe hypoxaemia in patients with chronic liver disease in the absence of intrinsic lung disease, the hepatopulmonary syndrome, is associated with pulmonary vascular dilatation and may be an indication for liver transplantation. Divergence between two methods of measuring right to left shunt (radiolabelled albumin macroaggregates and 100% oxygen breathing) has been described, but the mechanism and reason for the inter-patient variability for this shunt difference are not well understood.
METHODS: Eight hepatopulmonary syndrome patients were studied, with characteristic pulmonary diffusion abnormalities (carbon monoxide transfer factor 41+/-5 (mean+/-SE)% predicted) and significant decreases in arterial oxygen saturation (%) on standing vs. supine (-10%+/-3) and on exercise vs. rest (-15%+/-2). All had hypoxaemia at rest (arterial oxygen tension 8.2+/-0.6 kPa), partially corrected by breathing 100% oxygen (48.2+/-8.8 kPa). Pulmonary angiography was performed and right to left shunt measured by two independent methods: (a) 100% oxygen breathing and (b) i.v. injection of radiolabelled microspheres.
RESULTS: Measurement of right to left shunt with 99mTc-labelled albumin macroaggregates confirmed significant intrapulmonary microvascular dilatation, i.e. an "anatomical" shunt equalling 32+/-4% of cardiac output. Shunt measurements made simultaneously by the classical 100% oxygen technique were significantly smaller (19+/-3%, p=0.01). For individuals, the difference between the 99mTc-albumin macroaggregate shunt and the 100% oxygen shunt ranged from 2% to 30% absolute, convergence suggesting larger shunt channels (pure anatomical shunt) and divergence representing a combination of anatomical shunt and alveolar-capillary diffusion limitation (smaller microvascular channels).
CONCLUSIONS: Hypoxaemia in the hepatopulmonary syndrome may be due functionally either to right to left shunting or to diffusion limitation, depending upon the degree of dilatation of the pulmonary microvessels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696496     DOI: 10.1016/s0168-8278(98)80182-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Hepatopulmonary syndromes.

Authors:  M J Krowka
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome.

Authors:  Mehri Najafi Sani; Hamid-Reza Kianifar; Abdolrazagh Kianee; Gholamreza Khatami
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 3.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors:  Michael J Krowka
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

4.  Hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Michael B Fallon
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

5.  Intra-pulmonary shunt and pulmonary gas exchange during exercise in humans.

Authors:  Michael K Stickland; Robert C Welsh; Mark J Haykowsky; Stewart R Petersen; William D Anderson; Dylan A Taylor; Marcel Bouffard; Richard L Jones
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

6.  Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.

Authors:  Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Steven Zacks; Kari E Roberts; Vijay H Shah; Neil Kaplowitz; Lisa Forman; Keith Wille; Steven M Kawut
Journal:  Gastroenterology       Date:  2008-06-20       Impact factor: 22.682

7.  Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome.

Authors:  Gokhan Tumgor; Afig Berdeli; Cigdem Arikan; Ertürk Levent; Sema Aydogdu
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

8.  Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.

Authors:  Hui Ying Zhang; De Wu Han; Ai Rong Su; Li Tong Zhang; Zhong Fu Zhao; Jing Quan Ji; Bao Hong Li; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

9.  Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.

Authors:  Ali Nawaz Khan; Hamdan Al-Jahdali; Khalid Abdullah; Klaus L Irion; Quratulain Sabih; Alaa Gouda
Journal:  Ann Thorac Med       Date:  2011-04       Impact factor: 2.219

10.  Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry.

Authors:  Peter Deibert; Hans-Peter Allgaier; Stefanie Loesch; Claudia Müller; Manfred Olschewski; Hinrich Hamm; Klaus-Peter Maier; Hubert Erich Blum
Journal:  BMC Gastroenterol       Date:  2006-04-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.